The assessment of left ventricular hypertrophy in hypertension

Kannel, 1996, Blood pressure as a cardiovascular risk factor: prevention and treatment, JAMA, 275, 1571, 10.1001/jama.1996.03530440051036

Kannel, 1970, Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study, Ann Intern Med, 72, 813, 10.7326/0003-4819-72-6-813

Levy, 1986, Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy, Circulation, 90, 1786, 10.1161/01.CIR.90.4.1786

Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203

Sundstrom, 2001, Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men, Circulation, 103, 2346, 10.1161/01.CIR.103.19.2346

Alfakih, 2004, New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI, Hypertension, 44, 175, 10.1161/01.HYP.0000135249.66192.30

Schillaci, 2000, Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension, Hypertension, 35, 580, 10.1161/01.HYP.35.2.580

Verdecchia, 2003, Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis, Am J Hypertens, 16, 895, 10.1016/S0895-7061(03)01018-5

Dahlof, 2002, Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet, 359, 995, 10.1016/S0140-6736(02)08089-3

Okin, 2003, Losartan Intervention for Endpoint reduction in hypertension Study I. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study, Circulation, 108, 684, 10.1161/01.CIR.0000083724.28630.C3

Devereux, 2004, Prognostic significance of left ventricular mass change during treatment of hypertension, JAMA, 292, 2350, 10.1001/jama.292.19.2350

Committee, 2003, 2003 European Society of Hypertesion – European Society of Cardiology guidelines for the managment of arterial hypertension, J Hypertens, 21, 1011, 10.1097/00004872-200306000-00001

Okin, 1995, Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products, J Am Coll Cardiol, 25, 417, 10.1016/0735-1097(94)00371-V

Levy, 1990, Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy, Circulation, 81, 815, 10.1161/01.CIR.81.3.815

Devereux, 1993, Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease, Eur Heart J, 14, 8, 10.1093/eurheartj/14.suppl_D.8

Sokolow, 1949, The ventricular complex in left ventricular hypertrophy using a new electrocardiographic left ventricular hypertrophy as obtained by unipolar precordial and limb leads, Am Heart J, 37, 161, 10.1016/0002-8703(49)90562-1

Lewis, 1914, Observations upon ventricular hypertrophy with especial reference to preponderance of one or other chamber, Heart, 9, 91

Casale, 1987, Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings, Circulation, 75, 565, 10.1161/01.CIR.75.3.565

Romhilt, 1967, A point-score system for the ECG diagnosis of left ventricular hypertrophy, Am Heart J, 75, 752, 10.1016/0002-8703(68)90035-5

Schillaci, 1994, Improved electrocardiographic diagnosis of left ventricular hypertrophy, Am J Cardiol, 74, 714, 10.1016/0002-9149(94)90316-6

Verdecchia, 1998, Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension, J Am Coll Cardiol, 31, 383, 10.1016/S0735-1097(97)00493-2

Molloy, 1992, Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product, J Am Coll Cardiol, 20, 1180, 10.1016/0735-1097(92)90376-X

Okin, 1995, Gender differences and the electrocardiogram in left ventricular hypertrophy, Hypertension, 25, 242, 10.1161/01.HYP.25.2.242

Van Den Hoogen, 1992, Reproducibility of electrocardiographic criteria for left ventricular hypertrophy in hypertensive patients in general practice, Eur Heart J, 13, 1606, 10.1093/oxfordjournals.eurheartj.a060112

Devereux, 1977, Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method, Circulation, 55, 613, 10.1161/01.CIR.55.4.613

Devereux, 1986, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings, Am J Cardiol, 57, 450, 10.1016/0002-9149(86)90771-X

Salcedo, 1979, Left ventricular mass and wall thickness in hypertension. Comparison of M mode and two dimensional echocardiography in two experimental models, Am J Cardiol, 44, 936, 10.1016/0002-9149(79)90225-X

Korner, 1998, Assessment of prevalence of left ventricular hypertrophy in hypertension, J Hypertens, 16, 715, 10.1097/00004872-199816060-00001

Missouris, 1996, Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension, J Hypertens, 14, 1005, 10.1097/00004872-199608000-00011

Myerson, 2002, Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas, Hypertension, 40, 673, 10.1161/01.HYP.0000036401.99908.DB

Collins, 1989, Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography, J Am Coll Cardiol, 14, 672, 10.1016/0735-1097(89)90109-5

Byrd, 1989, Accuracy and reproducibility of clinically acquired two-dimensional echocardiographic mass measurements, Am Heart J, 118, 133, 10.1016/0002-8703(89)90083-5

Tsujita-Kuroda, 2000, Validity and reproducibility of echocardiographic measurement of left ventricular ejection fraction by acoustic quantification with tissue harmonic imaging technique, J Am Soc Echocardiogr, 13, 300, 10.1067/mje.2000.103962

Yu, 2000, Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients, J Am Soc Echocardiogr, 13, 216, 10.1067/mje.2000.103597

McGavigan, 2003, Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography, Eur J Echocardiogr, 4, 178, 10.1016/S1525-2167(02)00164-6

Alfakih, 2004, A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension, Eur J Radiol, 52, 103, 10.1016/j.ejrad.2003.09.015

Levy, 1987, Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study, Am J Cardiol, 59, 956, 10.1016/0002-9149(87)91133-7

Devereux, 1984, Standardization of M-mode echocardiographic left ventricular anatomic measurements, J Am Coll Cardiol, 4, 1222, 10.1016/S0735-1097(84)80141-2

de Simone, 1992, Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight, J Am Coll Cardiol, 20, 1251, 10.1016/0735-1097(92)90385-Z

Zoccali, 2001, Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis, J Am Soc Nephrol, 12, 2768, 10.1681/ASN.V12122768

Savage, 1987, The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study, Circulation, 75, 126

Ganau, 1550, Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension, J Am Coll Cardiol, 19, 1550, 10.1016/0735-1097(92)90617-V

Krumholz, 1995, Prognosis of left ventricular geometric patterns in the Framingham Heart Study, J Am Coll Cardiol, 25, 879, 10.1016/0735-1097(94)00473-4

Verdecchia, 1995, Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass, J Am Coll Cardiol, 25, 871, 10.1016/0735-1097(94)00424-O

Verdecchia, 1996, Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy, Am J Cardiol, 78, 197, 10.1016/S0002-9149(96)00256-1

Buck, 1997, Tomographic three-dimensional echocardiographic determination of chamber size and systolic function in patients with left ventricular aneurysm: comparison to magnetic resonance imaging, cineventriculography, and two-dimensional echocardiography, Circulation, 96, 4286, 10.1161/01.CIR.96.12.4286

Gutberlet, 2003, Evaluation of left ventricular volumes in patients with congenital heart disease and abnormal left ventricular geometry. Comparison of MRI and transthoracic 3-dimensional echocardiography, Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, 175, 942

von Bardeleben, 2004, Second-generation real-time three-dimensional echocardiography., Finally on its way into clinical cardiology Z Kardiol, 93, IV56

Kuhl, 2004, High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging, J Am Coll Cardiol, 43, 2083, 10.1016/j.jacc.2004.01.037

Sakuma, 1993, Evaluation of left ventricular volume and mass with breath-hold cine MR imaging, Radiology, 188, 377, 10.1148/radiology.188.2.8327681

Pattynama, 1993, Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis, Radiology, 187, 261, 10.1148/radiology.187.1.8451425

Katz, 1988, Estimation of human myocardial mass with MR imaging, Radiology, 169, 495, 10.1148/radiology.169.2.2971985

Florentine, 1986, Measurement of left ventricular mass in vivo using gated nuclear magnetic resonance imaging, J Am Coll Cardiol, 8, 107, 10.1016/S0735-1097(86)80099-7

Keller, 1986, In vivo measurement of myocardial mass using nuclear magnetic resonance imaging, J Am Coll Cardiol, 8, 113, 10.1016/S0735-1097(86)80100-0

Bottini, 1995, Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient, Am J Hypertens, 8, 221, 10.1016/0895-7061(94)00178-E

Papavassiliu, 2004, Accuracy of one- and two-dimensional algorithms with optimal image plane position for the estimation of left ventricular mass: a comparative study using magnetic resonance imaging, J Cardiovasc Magn Reson, 6, 845, 10.1081/JCMR-200036157

Plein, 2001, Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging, J Magn Reson Imaging, 14, 230, 10.1002/jmri.1178

Alfakih, 2003, Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences, J Magn Reson Imaging, 17, 323, 10.1002/jmri.10262

Grothues, 2002, Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy, Am J Cardiol, 90, 29, 10.1016/S0002-9149(02)02381-0

de Simone, 1999, Reliability and limitations of echocardiographic measurement of left ventricular mass for risk stratification and follow-up in single patients: the RES trial. Working Group on Heart and Hypertension of the Italian Society of Hypertension. Reliability of M-mode Echocardiographic Studies, J Hypertens, 17, 1955, 10.1097/00004872-199917121-00027

Muiesan, 2004, Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients, Hypertension, 43, 731, 10.1161/01.HYP.0000121223.44837.de